The Third UN High-Level Meeting on Non-Communicable Diseases (NCDs) Convened -NCDs as the Leading Cause of Death Worldwide-; Health and Global Policy Institute Co-signs NCDs Civil Society Statement
date : 9/28/2018
Tags: NCDs
On September 27, 2018, the Political Declaration of the third UN High-Level Meeting on Non-Communicable Diseases was adopted by member states including Japan. In response to this Political Declaration, the NCD Alliance, a collaborative platform that has expanded to around 170 countries, and nearly 300 civil society organisations declared a statement. The Health and Global Policy Institute (HGPI) aligns with the points outlined and has co-signed this civil society statement.
The global community is working towards accelerating progress towards the prevention and control of NCDs, however it is said that at the current rate of progress, more than half of all countries in the world will fail to meet the Sustainable Development Goal (SDG) target 3.4* by 2030.
In order to confront the current situation and challenges in NCDs prevention and control, HGPI will continue to promote this momentum as Japan’s official NCD Alliance point-of contact. HGPI continues to facilitate global forums within each NCD therapeutic area to crystalize policy issues from patients’ perspectives, to propose necessary policies, and to bring together multi-stakeholders such as industry, academia, policy makers, and civil society including patient leaders from both inside and outside Japan to amass discussion on a level playing field. On May 29, 2018, HGPI hosted the NCD Global Forum for Civil Society, Diabetes Session – Patient Leader Workshops and Open Forum.
*by 2030 reduce by one-third pre-mature mortality from NCDs through prevention and treatment, and promote mental health and wellbeing
Read full civil society statement here. (English only)
ENOUGH: over 300 organisations and experts calls on world leaders to seize the ‘do or die’ moment of the third UN High-Level Meeting to address NCDs
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)